086450.KQライブシグナル | Getagraph.comで利益を最大化

Live Chart Being Loaded With Signals

Commentary (3 5月 2024 @ 15:30):

Stats
本日の出来高	138 656
平均出来高	191 121
時価総額	721.46B
EPS	KRW0 ( 2024-03-14 )
次の収益日	( KRW0 ) 2024-05-12
Last Dividend	KRW0 ( N/A )
Next Dividend	KRW0 ( N/A )
P/E	0
ATR14	KRW25.70 (0.15%)

ボリューム相関

長: 0.28 (neutral)

短: -0.54 (weak negative)

Signal:(60.14) Neutral

DongKook Pharmaceutical 相関

10 最も正の相関

10 最も負の相関

知っていましたか？

相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関（1つの変数が増加すると、もう一方は減少する）、1は完全な正の相関（1つの変数が増加すると、もう一方も増加する）、0は相関がないことを示します（変数間に関係がない）。

相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。

DongKook Pharmaceutical 相関 - 通貨/商品

-0.73
( moderate negative )

-0.55
( weak negative )

0.04
( neutral )

-0.58
( weak negative )

0.64
( weak )

DongKook Pharmaceutical 財務諸表

Annual	2023
収益:	KRW730.99B
総利益:	KRW405.04B (55.41 %)
EPS:	KRW1 073.13

FY	2023
収益:	KRW730.99B
総利益:	KRW405.04B (55.41 %)
EPS:	KRW1 073.13

FY	2022
収益:	KRW661.65B
総利益:	KRW375.19B (56.71 %)
EPS:	KRW1 203.46

Financial Reports:

No articles found.

DongKook Pharmaceutical

DongKook Pharmaceutical Co., Ltd. provides pharmaceutical products in South Korea and internationally. It produces active pharmaceutical ingredients, including propofol, streptokinase, and teicoplanin; disposable syringes; and pills, capsules, and ointments, as well as small volume parentral, large volume parentral, and lyophilized injectable drug injections. The company also offers Teicon, Durakinase, and Lorelin Depot injections; produces various natural product materials, such as black cohosh extract and magnolia extract comprises ETIZM and TECA; and natural herb medicines. In addition, it provides general and prescription-based drugs; medical devices; ETC and cosmetic products; and quasi drugs that include lipossol hydrocare bandage. DongKook Pharmaceutical Co., Ltd. also exports its products to approximately 40 countries, including Japan, Europe, Central and South America, and India. The company was formerly known as UEC & Co., Ltd. and changed its name to DongKook Pharmaceutical Co., Ltd. in March 1982. DongKook Pharmaceutical Co., Ltd. was founded in 1968 and is headquartered in Seoul, South Korea.